AU782653B2 - Composition to be administered through mucous membrane - Google Patents

Composition to be administered through mucous membrane Download PDF

Info

Publication number
AU782653B2
AU782653B2 AU74284/00A AU7428400A AU782653B2 AU 782653 B2 AU782653 B2 AU 782653B2 AU 74284/00 A AU74284/00 A AU 74284/00A AU 7428400 A AU7428400 A AU 7428400A AU 782653 B2 AU782653 B2 AU 782653B2
Authority
AU
Australia
Prior art keywords
vesicles
antigen
use according
composition
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU74284/00A
Other languages
English (en)
Other versions
AU7428400A (en
Inventor
Sophie Gaubert
Rene Laversanne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capsulis SA
Original Assignee
Capsulis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsulis SA filed Critical Capsulis SA
Publication of AU7428400A publication Critical patent/AU7428400A/en
Application granted granted Critical
Publication of AU782653B2 publication Critical patent/AU782653B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU74284/00A 1999-09-14 2000-09-13 Composition to be administered through mucous membrane Ceased AU782653B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9911465A FR2798288B1 (fr) 1999-09-14 1999-09-14 Compositions vaccinales destinees a une administration par voie muqueuse
FR99/11465 1999-09-14
PCT/FR2000/002523 WO2001019335A2 (fr) 1999-09-14 2000-09-13 Compositions destinees a une administration par voie muqueuse

Publications (2)

Publication Number Publication Date
AU7428400A AU7428400A (en) 2001-04-17
AU782653B2 true AU782653B2 (en) 2005-08-18

Family

ID=9549811

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74284/00A Ceased AU782653B2 (en) 1999-09-14 2000-09-13 Composition to be administered through mucous membrane

Country Status (6)

Country Link
EP (1) EP1212043A2 (fr)
JP (1) JP2003509352A (fr)
AU (1) AU782653B2 (fr)
CA (1) CA2384876A1 (fr)
FR (1) FR2798288B1 (fr)
WO (1) WO2001019335A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2850872A1 (fr) * 2003-02-12 2004-08-13 Ethypharm Sa Composition vaccinale destinee a induire une reponse immunitaire contre le virus responsable du sida
JP2007512304A (ja) * 2003-11-29 2007-05-17 パッション フォー ライフ ヘルスケア リミテッド 組成物及び送達システム
FR2868951B1 (fr) * 2004-04-15 2006-07-21 Ethypharm Sa Compositions contenant ds vesicules lamellaires incorporant un principe actif peu soluble dans l'eau et produits intermediaires utiles pour leur preparation
WO2010029374A1 (fr) 2008-09-12 2010-03-18 Critical Pharmaceuticals Limited Améliorations apportées à l’absorption d’agents thérapeutiques à travers des membranes de muqueuses ou à travers la peau

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769022B1 (fr) * 1997-09-29 2000-11-03 Capsulis Vecteurs d'antigenes et compositions therapeutiques contenant des antigenes
US6271200B1 (en) * 1998-12-21 2001-08-07 Generex Pharmaceuticals Inc. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles

Also Published As

Publication number Publication date
JP2003509352A (ja) 2003-03-11
FR2798288A1 (fr) 2001-03-16
CA2384876A1 (fr) 2001-03-22
AU7428400A (en) 2001-04-17
WO2001019335A3 (fr) 2001-10-04
FR2798288B1 (fr) 2001-11-30
EP1212043A2 (fr) 2002-06-12
WO2001019335A2 (fr) 2001-03-22

Similar Documents

Publication Publication Date Title
Shukla et al. Bilosomes in the context of oral immunization: development, challenges and opportunities
ES2258108T3 (es) Vacunas con respuesta inmune mejorada y procedimientos de preparacion de las mismas.
US5709879A (en) Vaccine compositions containing liposomes
JP2502234B2 (ja) リポソ―ム含有ワクチン組成物
DE69314020T2 (de) Impfstoffe die nicht ionische tensid vesikeln enthalften
EP1574210B1 (fr) Microemulsions à macromolécules adsorbées
US5876721A (en) Vaccines
RU2126270C1 (ru) Композиция для индукции иммунной реакции у млекопитающего и способ введения млекопитающему активного ингредиента
DE60310562T2 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
JPH11512712A (ja) 生物学的に活性な物質を細胞に送達するためのエマルジョンおよびミセル処方物
Jain et al. Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization
AU2002350974A1 (en) Outer membrane vesicles from gram negative bacteria and use as a vaccine
NZ262597A (en) Vaccine containing a specific antigen and a lymphoid organ modifier which is a retinoic acid, retinol, glucocorticoid, or vitamin d3 derivative
KR20020012221A (ko) 체액성 및 세포성 면역 반응을 증진시키기 위한, 안정성과생체 적합성이 최적화된 애쥬반트
CN106029090A (zh) 疫苗与佐剂的组合物以及治疗尿路感染的方法
WO1997030726A1 (fr) Molecules hydrophobes receptrices de substances antigenes et comprenant des complexes immuno-stimulants ou des matrices de complexes immuno-stimulants
JPH08507077A (ja) ワクチン送達系、および活性成分の遠隔封入のための保存安定性前駆溶液
AU782653B2 (en) Composition to be administered through mucous membrane
Bhairy et al. Stability and In-vivo Efficacy of Bile salts containing vesicles (Bilosomes) for oral delivery of vaccines and poorly soluble active drug molecules
Sachetelli et al. Evaluation of the pulmonary and systemic immunogenicity of fluidosomes, a fluid liposomal–tobramycin formulation for the treatment of chronic infections in lungs
AU744308B2 (en) Antigen vectors in the form of multilamellar vesicles
EP2347764A2 (fr) Procédé pour obtenir des structures cochléaires, des compositions de vaccins, des adjuvants et leurs intermédiaires
Shu et al. Chitosan particle stabilized Pickering emulsion/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice
WO2000076476A1 (fr) Liposomes polymerises a base d'adjuvant pour vaccination par voie orale, muqueuse ou intranasale
DE69505236T2 (de) Liposomen und deren verwendung insbesondere zur herstellung immunomodulatorischer mittel

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 27, PAGE(S) 5693-5698 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 72982/00, 72989/00, 72994/00, 72995/00, 72997/00, 74226/00, 74272/00, 74284/00, 74300/00, 74301/00, 75071/00, 75264/00, 75267/00, 75274/00, 75275/00, 77707/00